600 filings
Page 14 of 30
CORRESP
932i99w3as qgqwb8
12 Dec 14
Correspondence with SEC
12:00am
8-K
5i78v819937dngjz2m9
2 Dec 14
Regulation FD Disclosure
12:00am
CORRESP
jltudj2 7ynxs
1 Dec 14
Correspondence with SEC
12:00am
UPLOAD
iw74e
14 Nov 14
Letter from SEC
12:00am
NT 10-Q
454ub pdvethuy
14 Nov 14
Notice of late quarterly filing
12:00am
CORRESP
u34ix8f8kebs212t9
20 Oct 14
Correspondence with SEC
12:00am
8-K
tbvb1fq l9y
10 Oct 14
NW Bio Announces $11.5 Million Financing
12:00am
424B5
mvdhm
8 Oct 14
Prospectus supplement for primary offering
12:00am
UPLOAD
o5az0 zplpenpdhm7w
29 Sep 14
Letter from SEC
12:00am
8-K
9piym3b1mc lmb7
18 Sep 14
NW Bio’s Cancer Vaccine Is the First Drug to Be Designated
12:00am
8-K
b3hcu24w0n 02wa6d
25 Aug 14
Entry into a Material Definitive Agreement
12:00am
8-K
6tzo0bdwg5
19 Aug 14
NW Bio Announces Pricing Of $17.5 Million Offering Of Convertible Notes
12:00am
NT 10-Q
59bl1wr
14 Aug 14
Notice of late quarterly filing
12:00am
8-K
mlui02 42duq
11 Aug 14
NW BIO Obtains Approvals for Enhancements of Phase III Trial of
12:00am
8-K
er3hr
22 Jul 14
NW Bio Announces Completion of
12:00am